Kelly Moore1, Luohua Jiang, Spero M Manson, Janette Beals, William Henderson, Katherine Pratte, Kelly J Acton, Yvette Roubideaux. 1. Kelly Moore, Spero M. Manson, Janette Beals, William Henderson, and Katherine Pratte are with the Centers for American Indian and Alaska Native Health, School of Public Health, University of Colorado Denver, Aurora. Luohua Jiang is with the Department of Epidemiology and Biostatistics, School of Rural Public Health, Texas A&M Health Science Center, College Station. Kelly J. Acton is with the Office of the Assistant Secretary of Health, US Department of Health and Human Services, San Francisco, CA. Yvette Roubideaux is with the Office of the Director, Indian Health Service (IHS), Rockville, MD.
Abstract
OBJECTIVES: We evaluated cardiovascular disease (CVD) risk factors in American Indians/Alaska Natives (AI/ANs) with diabetes in the Special Diabetes Program for Indians Healthy Heart (SDPI-HH) Demonstration Project. METHODS: Multidisciplinary teams implemented an intensive case management intervention among 30 health care programs serving 138 tribes. The project recruited 3373 participants, with and without current CVD, between 2006 and 2009. We examined data collected at baseline and 1 year later to determine whether improvements occurred in CVD risk factors and in Framingham coronary heart disease (CHD) risk scores, aspirin use, and smoking status. RESULTS: A1c levels decreased an average of 0.2% (P < .001). Systolic and diastolic blood pressure, low-density lipoprotein (LDL) cholesterol, and triglyceride levels decreased, with the largest significant reduction in LDL cholesterol (∆ = -5.29 mg/dL; P < .001). Average Framingham CHD risk scores also decreased significantly. Aspirin therapy increased significantly, and smoking decreased. Participants with more case management visits had significantly greater reductions in LDL cholesterol and A1c values. CONCLUSIONS: SDPI-HH successfully translated an intensive case management intervention. Creative retention strategies and an improved understanding of organizational challenges are needed for future Indian health translational efforts.
OBJECTIVES: We evaluated cardiovascular disease (CVD) risk factors in American Indians/Alaska Natives (AI/ANs) with diabetes in the Special Diabetes Program for Indians Healthy Heart (SDPI-HH) Demonstration Project. METHODS: Multidisciplinary teams implemented an intensive case management intervention among 30 health care programs serving 138 tribes. The project recruited 3373 participants, with and without current CVD, between 2006 and 2009. We examined data collected at baseline and 1 year later to determine whether improvements occurred in CVD risk factors and in Framingham coronary heart disease (CHD) risk scores, aspirin use, and smoking status. RESULTS: A1c levels decreased an average of 0.2% (P < .001). Systolic and diastolic blood pressure, low-density lipoprotein (LDL) cholesterol, and triglyceride levels decreased, with the largest significant reduction in LDL cholesterol (∆ = -5.29 mg/dL; P < .001). Average Framingham CHD risk scores also decreased significantly. Aspirin therapy increased significantly, and smoking decreased. Participants with more case management visits had significantly greater reductions in LDL cholesterol and A1c values. CONCLUSIONS:SDPI-HH successfully translated an intensive case management intervention. Creative retention strategies and an improved understanding of organizational challenges are needed for future Indian health translational efforts.
Authors: Kaveh G Shojania; Sumant R Ranji; Kathryn M McDonald; Jeremy M Grimshaw; Vandana Sundaram; Robert J Rushakoff; Douglas K Owens Journal: JAMA Date: 2006-07-26 Impact factor: 56.272
Authors: Ying Zhang; James M Galloway; Thomas K Welty; David O Wiebers; Jack P Whisnant; Richard B Devereux; Jorge R Kizer; Barbara V Howard; Linda D Cowan; Jeunliang Yeh; W James Howard; Wenyu Wang; Lyle Best; Elisa T Lee Journal: Circulation Date: 2008-09-22 Impact factor: 29.690
Authors: David M Scott; Steven T Boyd; Michelle Stephan; Sam C Augustine; Thomas P Reardon Journal: Am J Health Syst Pharm Date: 2006-11-01 Impact factor: 2.637
Authors: Jun Ma; Kathy Berra; William L Haskell; Linda Klieman; Shauna Hyde; Mark W Smith; Lan Xiao; Randall S Stafford Journal: Arch Intern Med Date: 2009-11-23
Authors: Katherine A Pratte; Janette Beals; Ann Johnson; Ann Bullock; Spero M Manson; Luohua Jiang Journal: Transl Behav Med Date: 2019-07-16 Impact factor: 3.046
Authors: Kelly R Moore; Emily B Schroeder; Glenn K Goodrich; Spero M Manson; Allen S Malone; Lisa E Pieper; Linda Son-Stone; David Johnson; John F Steiner Journal: J Racial Ethn Health Disparities Date: 2022-05-03
Authors: Joan M O'Connell; Jennifer E Rockell; Judith C Ouellet; Sherri Yoder; Kimberly E Lind; Charlton Wilson; Andrew Friedson; Spero M Manson Journal: EC Endocrinol Metab Res Date: 2021-01-27
Authors: Khadijah Breathett; Mario Sims; Marie Gross; Elizabeth A Jackson; Emily J Jones; Ana Navas-Acien; Herman Taylor; Kevin L Thomas; Barbara V Howard Journal: Circulation Date: 2020-05-28 Impact factor: 29.690
Authors: Heather D Gibbs; Christina Pacheco; Hung-Wen Yeh; Christine Daley; K Allen Greiner; Won S Choi Journal: Am J Prev Med Date: 2016-07-21 Impact factor: 5.043
Authors: Joan O'Connell; Margaret Reid; Jennifer Rockell; Kathleen Harty; Marcelo Perraillon; Spero Manson Journal: Med Care Date: 2021-06-01 Impact factor: 3.178